This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gall, J. G. D.
Right arrow Articles by Falck-Pedersen, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gall, J. G. D.
Right arrow Articles by Falck-Pedersen, E.

 Previous Article  |  Next Article 

Journal of Virology, December 1998, p. 10260-10264, Vol. 72, No. 12
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Construction and Characterization of Hexon-Chimeric Adenoviruses: Specification of Adenovirus Serotype

Jason G. D. Gall,1,dagger Ronald G. Crystal,2 and Erik Falck-Pedersen1,*

Department of Microbiology, W. R. Hearst Research Foundation,1 and Department of Medicine,2 Cornell University Medical College, New York, New York 10021

Received 22 June 1998/Accepted 9 September 1998

This study has used the strategy of gene replacement to characterize the contribution of the adenovirus (Ad) capsid protein hexon to serotype definition. By replacing the Ad type 5 (Ad5) hexon gene with sequences from Ad2, we have changed the type specificity of the chimeric virus. The type-determining epitopes are primarily associated with loop 1 of hexon and, to a much lesser degree, with loop 2. In spite of the serotype distinctiveness of the chimeric hexon viruses, epitope similarity between the vectors resulted in a low level of cross-reactive neutralizing antibody, which in combination with activated cellular and innate arms of the immune system is sufficient to suppress gene transduction following readministration in vivo.


* Corresponding author. Mailing address: Department of Microbiology, Box 62, Cornell University Medical College, 1300 York Ave., New York, NY 10021. Phone: (212) 746-6514. Fax: (212) 746-8587. E-mail: efalckp{at}mail.med.cornell.edu.

dagger Present address: Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA 92037.


Journal of Virology, December 1998, p. 10260-10264, Vol. 72, No. 12
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Kaneko, H., Iida, T., Ishiko, H., Ohguchi, T., Ariga, T., Tagawa, Y., Aoki, K., Ohno, S., Suzutani, T. (2009). Analysis of the complete genome sequence of epidemic keratoconjunctivitis-related human adenovirus type 8, 19, 37 and a novel serotype. J. Gen. Virol. 90: 1471-1476 [Abstract] [Full Text]  
  • Russell, W. C. (2009). Adenoviruses: update on structure and function. J. Gen. Virol. 90: 1-20 [Abstract] [Full Text]  
  • Aoki, K., Ishiko, H., Konno, T., Shimada, Y., Hayashi, A., Kaneko, H., Ohguchi, T., Tagawa, Y., Ohno, S., Yamazaki, S. (2008). Epidemic Keratoconjunctivitis Due to the Novel Hexon-Chimeric-Intermediate 22,37/H8 Human Adenovirus. J. Clin. Microbiol. 46: 3259-3269 [Abstract] [Full Text]  
  • Schoenly, K. A., Weiner, D. B. (2008). Human Immunodeficiency Virus Type 1 Vaccine Development: Recent Advances in the Cytotoxic T-Lymphocyte Platform "Spotty Business". J. Virol. 82: 3166-3180 [Full Text]  
  • Schepp-Berglind, J., Luo, M., Wang, D., Wicker, J. A., Raja, N. U., Hoel, B. D., Holman, D. H., Barrett, A. D. T., Dong, J. Y. (2007). Complex Adenovirus-Mediated Expression of West Nile Virus C, PreM, E, and NS1 Proteins Induces both Humoral and Cellular Immune Responses. CVI 14: 1117-1126 [Abstract] [Full Text]  
  • Madisch, I., Harste, G., Pommer, H., Heim, A. (2005). Phylogenetic Analysis of the Main Neutralization and Hemagglutination Determinants of All Human Adenovirus Prototypes as a Basis for Molecular Classification and Taxonomy. J. Virol. 79: 15265-15276 [Abstract] [Full Text]  
  • Nanda, A., Lynch, D. M., Goudsmit, J., Lemckert, A. A. C., Ewald, B. A., Sumida, S. M., Truitt, D. M., Abbink, P., Kishko, M. G., Gorgone, D. A., Lifton, M. A., Shen, L., Carville, A., Mansfield, K. G., Havenga, M. J. E., Barouch, D. H. (2005). Immunogenicity of Recombinant Fiber-Chimeric Adenovirus Serotype 35 Vector-Based Vaccines in Mice and Rhesus Monkeys. J. Virol. 79: 14161-14168 [Abstract] [Full Text]  
  • Schoggins, J. W., Nociari, M., Philpott, N., Falck-Pedersen, E. (2005). Influence of Fiber Detargeting on Adenovirus-Mediated Innate and Adaptive Immune Activation. J. Virol. 79: 11627-11637 [Abstract] [Full Text]  
  • Sumida, S. M., Truitt, D. M., Lemckert, A. A. C., Vogels, R., Custers, J. H. H. V., Addo, M. M., Lockman, S., Peter, T., Peyerl, F. W., Kishko, M. G., Jackson, S. S., Gorgone, D. A., Lifton, M. A., Essex, M., Walker, B. D., Goudsmit, J., Havenga, M. J. E., Barouch, D. H. (2005). Neutralizing Antibodies to Adenovirus Serotype 5 Vaccine Vectors Are Directed Primarily against the Adenovirus Hexon Protein. J. Immunol. 174: 7179-7185 [Abstract] [Full Text]  
  • Wu, H., Han, T., Belousova, N., Krasnykh, V., Kashentseva, E., Dmitriev, I., Kataram, M., Mahasreshti, P. J., Curiel, D. T. (2005). Identification of Sites in Adenovirus Hexon for Foreign Peptide Incorporation. J. Virol. 79: 3382-3390 [Abstract] [Full Text]  
  • Sumida, S. M., Truitt, D. M., Kishko, M. G., Arthur, J. C., Jackson, S. S., Gorgone, D. A., Lifton, M. A., Koudstaal, W., Pau, M. G., Kostense, S., Havenga, M. J. E., Goudsmit, J., Letvin, N. L., Barouch, D. H. (2004). Neutralizing Antibodies and CD8+ T Lymphocytes both Contribute to Immunity to Adenovirus Serotype 5 Vaccine Vectors. J. Virol. 78: 2666-2673 [Abstract] [Full Text]  
  • Rux, J. J., Kuser, P. R., Burnett, R. M. (2003). Structural and Phylogenetic Analysis of Adenovirus Hexons by Use of High-Resolution X-Ray Crystallographic, Molecular Modeling, and Sequence-Based Methods. J. Virol. 77: 9553-9566 [Abstract] [Full Text]  
  • Barouch, D. H., McKay, P. F., Sumida, S. M., Santra, S., Jackson, S. S., Gorgone, D. A., Lifton, M. A., Chakrabarti, B. K., Xu, L., Nabel, G. J., Letvin, N. L. (2003). Plasmid Chemokines and Colony-Stimulating Factors Enhance the Immunogenicity of DNA Priming-Viral Vector Boosting Human Immunodeficiency Virus Type 1 Vaccines. J. Virol. 77: 8729-8735 [Abstract] [Full Text]  
  • Adhikary, A K, Numaga, J, Kaburaki, T, Kawashima, H, Araie, M, Ikeda, Y, Ogino, T, Suzuki, E, Ushijima, H, Mukoyama, A, Matsuno, S, Inada, T, Okabe, N (2003). Genetic characterisation of adenovirus type 8 isolated in Hiroshima city over a 15 year period. J. Clin. Pathol. 56: 120-125 [Abstract] [Full Text]  
  • Wu, H., Dmitriev, I., Kashentseva, E., Seki, T., Wang, M., Curiel, D. T. (2002). Construction and Characterization of Adenovirus Serotype 5 Packaged by Serotype 3 Hexon. J. Virol. 76: 12775-12782 [Abstract] [Full Text]  
  • Meyers, C., Bromberg-White, J. L., Zhang, J., Kaupas, M. E., Bryan, J. T., Lowe, R. S., Jansen, K. U. (2002). Infectious Virions Produced from a Human Papillomavirus Type 18/16 Genomic DNA Chimera. J. Virol. 76: 4723-4733 [Abstract] [Full Text]  
  • Farina, S. F., Gao, G.-p., Xiang, Z. Q., Rux, J. J., Burnett, R. M., Alvira, M. R., Marsh, J., Ertl, H. C. J., Wilson, J. M. (2001). Replication-Defective Vector Based on a Chimpanzee Adenovirus. J. Virol. 75: 11603-11613 [Abstract] [Full Text]  
  • Imai, Y., Kameya, S., Ohkoshi, M., Yamaki, K., Sakuragi, S. (2001). Identification of the Hexon Region of an Adenovirus Involved in a New Outbreak of Keratoconjunctivitis. J. Clin. Microbiol. 39: 2975-2977 [Abstract] [Full Text]  
  • Ostapchuk, P., Hearing, P. (2001). Pseudopackaging of Adenovirus Type 5 Genomes into Capsids Containing the Hexon Proteins of Adenovirus Serotypes B, D, or E. J. Virol. 75: 45-51 [Abstract] [Full Text]